Pharma & Biotech
Humanigen pins hopes on monoclonal antibody treatment of cancer therapy's side effects
Namaste Technologies looks to become the ‘Amazon of cannabis’ with its integrated, intelligent cannabis experience
AusCann Group on track to produce cannabinoid medicines this year
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.